Niizalactams A-C, Multicyclic Macrolactams Isolated from Combined Culture of Streptomyces with Mycolic Acid-Containing Bacterium

J Nat Prod. 2015 Dec 24;78(12):3011-7. doi: 10.1021/acs.jnatprod.5b00804. Epub 2015 Dec 1.

Abstract

A terrestrial bacterium, Streptomyces sp. NZ-6, produced niizalactams A-C (1-3), unprecedented di- and tricyclic macrolactams, by coculturing with the mycolic acid-containing bacterium Tsukamurella pulmonis TP-B0596. Their complete structures, including absolute configurations, were elucidated on the basis of spectroscopic data and chemical derivatization. Their unique skeletons are proposed to be biosynthesized from a common 26-membered macrolactam intermediate by SN2 cyclization or an intramolecular Diels-Alder reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacillus subtilis / drug effects
  • Candida albicans / drug effects
  • Drug Screening Assays, Antitumor
  • Lactams, Macrocyclic / chemistry
  • Lactams, Macrocyclic / isolation & purification*
  • Lactams, Macrocyclic / pharmacology
  • Leukemia P388
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Mycolic Acids / chemistry
  • Nuclear Magnetic Resonance, Biomolecular
  • Saccharomyces cerevisiae / drug effects
  • Streptomyces / chemistry*

Substances

  • Lactams, Macrocyclic
  • Mycolic Acids
  • niizalactam A
  • niizalactam B
  • niizalactam C